Lux Bio Group, Inc.
Lux Bio Group, Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates across various regions, focusing on innovative solutions in life sciences. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced biopharmaceuticals and diagnostic tools, catering to the evolving needs of healthcare providers and patients alike. Lux Bio Group's core offerings include cutting-edge therapeutics and state-of-the-art diagnostic technologies, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including strategic partnerships and successful product launches, solidifying its market position. With a dedication to research and development, Lux Bio Group continues to push the boundaries of biotechnology, making a meaningful impact in the industry.
DitchCarbon Score
How does Lux Bio Group, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Communication Equipment Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lux Bio Group, Inc.'s score of 25 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lux Bio Group, Inc.'s reported carbon emissions
In 2023, Lux Bio Group, Inc. reported total carbon emissions of approximately 6,066,000 kg CO2e from Scope 2 and 347,000 kg CO2e from Scope 1. This marks a slight increase in Scope 2 emissions compared to 2022, where they were about 5,763,000 kg CO2e, while Scope 1 emissions decreased from 420,000 kg CO2e in the previous year. Despite these figures, Lux Bio Group has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets indicates a need for further commitment to climate action within the industry context. Overall, while Lux Bio Group has made some progress in managing their emissions, the lack of formal reduction strategies highlights an opportunity for enhanced climate commitments moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 420,000 | 000,000 |
| Scope 2 | 5,763,000 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lux Bio Group, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
